Your browser doesn't support javascript.
loading
Indications for islet or pancreatic transplantation: Statement of the TREPID working group on behalf of the Société francophone du diabète (SFD), Société francaise d'endocrinologie (SFE), Société francophone de transplantation (SFT) and Société française de néphrologie - dialyse - transplantation (SFNDT).
Wojtusciszyn, A; Branchereau, J; Esposito, L; Badet, L; Buron, F; Chetboun, M; Kessler, L; Morelon, E; Berney, T; Pattou, F; Benhamou, P-Y; Vantyghem, M-C.
Afiliação
  • Wojtusciszyn A; Department of endocrinology, diabetes and nutrition, university hospital of Montpellier, Lapeyronie hospital, laboratory of cell therapy for diabetes (LTCD), institute of regenerative medicine and biotherapy, (IRMB), university hospital of Montpellier, Saint-Éloi, hospital, IGF, CNRS UMR5203, Inserm
  • Branchereau J; Urology department, CHU de Nantes, centre de recherche en transplantation et immunologie, UMR 1064, Inserm, université de Nantes, institut de transplantation urologie néphrologie (ITUN), Nantes, France.
  • Esposito L; Department of nephrology, 38000 Toulouse, France.
  • Badet L; Hospices civils de Lyon, service d'urologie et de chirurgie de la transplantation, pôle Chirurgie, 69000 Lyon, France.
  • Buron F; Hospices civils de Lyon, service d'urologie et de chirurgie de la transplantation, pôle Chirurgie, 69000 Lyon, France; Inserm, U1055, 38000 Grenoble, France.
  • Chetboun M; University of Lille, Inserm, CHU de Lille, UMR 1190, translational research in diabetes, endocrine surgery, 59000 Lille, France; CHU Lille, endocrine surgery, 59000 Lille, France.
  • Kessler L; Department of Endocrinology and Diabetology, University Hospital of Strasbourg, 67000 Strasbourg, France; INSERM UMR 1260, Regenerative Nanomedecine, Federation of Translational Medicine, University of Strasbourg, 67000 Strasbourg, France.
  • Morelon E; Hospices civils de Lyon, service d'urologie et de chirurgie de la transplantation, pôle Chirurgie, 69000 Lyon, France.
  • Berney T; Division of Transplantation, Department of Surgery, University of Geneva Hospitals, Geneva, Switzerland.
  • Pattou F; University of Lille, Inserm, CHU de Lille, UMR 1190, translational research in diabetes, endocrine surgery, 59000 Lille, France; CHU Lille, endocrine surgery, 59000 Lille, France.
  • Benhamou PY; Department of Endocrinology, Pôle DigiDune, Grenoble University Hospital, Grenoble Alpes University, 38000 Grenoble, France; Grenoble Alpes University, LBFA, 38000, Grenoble, France.
  • Vantyghem MC; University of Lille, Inserm, CHU de Lille, UMR 1190, translational research in diabetes, endocrine surgery, 59000 Lille, France; CHU Lille, Endocrinology, diabetology and metabolism, 59000 Lille, France. Electronic address: mc-vantyghem@chru-lille.fr.
Diabetes Metab ; 45(3): 224-237, 2019 06.
Article em En | MEDLINE | ID: mdl-30223084

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante das Ilhotas Pancreáticas / Transplante de Pâncreas / Diabetes Mellitus Tipo 1 Tipo de estudo: Etiology_studies / Guideline / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante das Ilhotas Pancreáticas / Transplante de Pâncreas / Diabetes Mellitus Tipo 1 Tipo de estudo: Etiology_studies / Guideline / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article